Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
recAP in sepsis-associated acute kidney injury
NL-OMON44174Phase 2Active, not recruiting
- Sponsor
- AM-Pharma
- Start
- Mar 2015
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of ilofotase alfa, sponsored by AM-Pharma. Started Mar 2015; status: active, not recruiting.
02
Drugs
ilofotase alfa
Beyond the preview
Go deeper on NL-OMON44174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44174.